Page 6 - Multicenter Study News Today

Blue Earth Diagnostics Highlights Upcoming Presentation of Key Results from Phase 3 SPOTLIGHT Study of Targeted PET Imaging Agent 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer - read this article along with other careers information, tips and advice on BioSpace

BURLINGTON, Mass. & OXFORD, England--(BUSINESS WIRE)--Feb 1, 2022--

Buerger's disease, also known as thromboangiitis obliterans, is a rare condition that primarily affects young to middle-aged male smokers.

MARLBOROUGH, Mass. , Jan. 7, 2022 / / -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25 th North American Neuromodulation Society (NANS) annual meeting, in Orlando, Florida , on Jan.13-15, 2022. More than 20 abstracts have been accepted, including three late-breaking presentations.

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Kite’s Landmark CAR T-Cell Therapy Study ZUMA-7 in RelapsedRefractory Large B-Cell Lymphoma to be Featured in ASH Plenary Session – – Five Oral Presentations Highlight Kite’s Leadership in CAR T-Cell Therapies – – New Research on Magrolimab Provides Key Insights as Gilead Rapidly Expands Research in AML – Gilead Sciences, Inc. and Kite, a Gilead Company, today announced that data at the 63rd American ...

Numerous oral presentations highlighting data for tafasitamab, parsaclisib, ruxolitinib, pemigatinib, itacitinib and ponatinib to be highlighted during the Congress Incyte (Nasdaq:INCY) today announced

Amgen To Showcase New Data From Oncology Portfolio At ASCO 2021 LUMAKRAS™ (Sotorasib)¹ Overall Survival and Biomarker Subgroup Analyses From Registrational Phase 2 CodeBreaK 100 Trial in KRAS G12C-Mutated Non-Small Cell Lung Cancer New Data From the Phase 2 FIGHT Trial with Bemarituzumab in Advanced Gastric and Gastroesophageal Junction Cancers News provided by Share this article Share this article THOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that ...

Similar Long-Term Outcomes With and Without ECMO for Mechanically Ventilated COVID-19 Patients A nurse checking an ECMO system being used to support a critically ill COVID-19 patient at Banner Health in Phoenix. ECMO can offer both hemodynamic support and oxygenation for COVID patients who otherwise cannot get enough pulmonary support from ventilators, or are in danger of organ failure. May 4, 2021 – A new study, presented today at the 2021 American Association for Thoracic Surgery (AATS) 101...